PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
BVS vs. LFMD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BVS and LFMD is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

BVS vs. LFMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Bioventus Inc. (BVS) and LifeMD, Inc. (LFMD). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2025February
13.92%
56.27%
BVS
LFMD

Key characteristics

Sharpe Ratio

BVS:

1.97

LFMD:

0.30

Sortino Ratio

BVS:

2.93

LFMD:

0.99

Omega Ratio

BVS:

1.37

LFMD:

1.12

Calmar Ratio

BVS:

1.71

LFMD:

0.28

Martin Ratio

BVS:

9.32

LFMD:

0.52

Ulcer Index

BVS:

14.55%

LFMD:

46.78%

Daily Std Dev

BVS:

69.14%

LFMD:

80.51%

Max Drawdown

BVS:

-95.18%

LFMD:

-96.24%

Current Drawdown

BVS:

-45.91%

LFMD:

-72.90%

Fundamentals

Market Cap

BVS:

$679.17M

LFMD:

$349.34M

EPS

BVS:

-$0.61

LFMD:

-$0.64

Total Revenue (TTM)

BVS:

$419.64M

LFMD:

$135.08M

Gross Profit (TTM)

BVS:

$281.75M

LFMD:

$128.98M

EBITDA (TTM)

BVS:

$17.95M

LFMD:

-$10.22M

Returns By Period

In the year-to-date period, BVS achieves a -1.05% return, which is significantly lower than LFMD's 67.27% return.


BVS

YTD

-1.05%

1M

3.49%

6M

26.71%

1Y

129.36%

5Y*

N/A

10Y*

N/A

LFMD

YTD

67.27%

1M

68.98%

6M

59.23%

1Y

16.78%

5Y*

64.23%

10Y*

23.61%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

BVS vs. LFMD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BVS
The Risk-Adjusted Performance Rank of BVS is 8989
Overall Rank
The Sharpe Ratio Rank of BVS is 9191
Sharpe Ratio Rank
The Sortino Ratio Rank of BVS is 9090
Sortino Ratio Rank
The Omega Ratio Rank of BVS is 8888
Omega Ratio Rank
The Calmar Ratio Rank of BVS is 8787
Calmar Ratio Rank
The Martin Ratio Rank of BVS is 9090
Martin Ratio Rank

LFMD
The Risk-Adjusted Performance Rank of LFMD is 5555
Overall Rank
The Sharpe Ratio Rank of LFMD is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of LFMD is 5757
Sortino Ratio Rank
The Omega Ratio Rank of LFMD is 5555
Omega Ratio Rank
The Calmar Ratio Rank of LFMD is 5858
Calmar Ratio Rank
The Martin Ratio Rank of LFMD is 5151
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BVS vs. LFMD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Bioventus Inc. (BVS) and LifeMD, Inc. (LFMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for BVS, currently valued at 1.97, compared to the broader market-2.000.002.004.001.970.30
The chart of Sortino ratio for BVS, currently valued at 2.93, compared to the broader market-6.00-4.00-2.000.002.004.006.002.930.99
The chart of Omega ratio for BVS, currently valued at 1.37, compared to the broader market0.501.001.502.001.371.12
The chart of Calmar ratio for BVS, currently valued at 1.71, compared to the broader market0.002.004.006.001.710.28
The chart of Martin ratio for BVS, currently valued at 9.32, compared to the broader market0.0010.0020.0030.009.320.52
BVS
LFMD

The current BVS Sharpe Ratio is 1.97, which is higher than the LFMD Sharpe Ratio of 0.30. The chart below compares the historical Sharpe Ratios of BVS and LFMD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00SeptemberOctoberNovemberDecember2025February
1.97
0.30
BVS
LFMD

Dividends

BVS vs. LFMD - Dividend Comparison

Neither BVS nor LFMD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

BVS vs. LFMD - Drawdown Comparison

The maximum BVS drawdown since its inception was -95.18%, roughly equal to the maximum LFMD drawdown of -96.24%. Use the drawdown chart below to compare losses from any high point for BVS and LFMD. For additional features, visit the drawdowns tool.


-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%-30.00%SeptemberOctoberNovemberDecember2025February
-45.91%
-72.90%
BVS
LFMD

Volatility

BVS vs. LFMD - Volatility Comparison

The current volatility for Bioventus Inc. (BVS) is 9.06%, while LifeMD, Inc. (LFMD) has a volatility of 17.71%. This indicates that BVS experiences smaller price fluctuations and is considered to be less risky than LFMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%30.00%35.00%SeptemberOctoberNovemberDecember2025February
9.06%
17.71%
BVS
LFMD

Financials

BVS vs. LFMD - Financials Comparison

This section allows you to compare key financial metrics between Bioventus Inc. and LifeMD, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab